• SEMA3E Promotes Beige Fat Thermogenesis via β-Catenin

  2026-09-27

  A mouse study identifies SEMA3E as a regulator of beige adipocyte differentiation and thermogenesis, linking its effects to mitochondrial oxidative phosphorylation and β-catenin signaling. The findings support further investigation of SEMA3E in adipose biology while leaving the precise pathway dynamics and relevance to human tissue unresolved.

• Fzd5 Connects Cholesterol to Wnt Signaling in PDAC

  2026-09-26

  The study identifies Frizzled5 (Fzd5) as a cholesterol-binding Wnt receptor and links cholesterol recognition to receptor palmitoylation, cell-surface trafficking, and Wnt/β-catenin activity in pancreatic cancer models. It provides a mechanistic explanation for how altered lipid metabolism can support Wnt-dependent tumor growth, while positioning cholesterol competition as a preclinical research avenue rather than an established treatment.

• Pertussis toxin: workflows for signaling research

  2026-09-25

  Pertussis toxin offers researchers a way to probe Gi/o-linked signaling, from immune assays to a behaviorally distinct test of serotonergic dose responses. This guide translates a mouse study into practical workflow choices while separating its reported conditions from assay-design recommendations.

• AP20187: Chemical Inducer of Dimerization Workflows

  2026-09-25

  AP20187 gives researchers a controllable way to activate engineered fusion proteins, with practical uses in reporter assays, conditional signaling, and regulated cell therapy research. Here, workflows are framed alongside a chronic intermittent hypoxia study—while clearly separating its macrophage findings from AP20187 applications that would require new engineered models.

• Deferoxamine Mesylate in Iron-Redox Assays

  2026-09-24

  Use Deferoxamine mesylate to probe how iron availability shapes oxidative-stress, HIF-1α, and tissue-protection readouts. A practical workflow pairs dose controls with rapid ROS measurements—while keeping clear that the featured platinum study does not establish an iron-dependent mechanism.

• Tricine-SDS-PAGE Gel Preparation Kit for Peptides

  2026-09-24

  This kit supports protein electrophoresis and peptide separation when conventional Tris-SDS-PAGE does not adequately resolve low-molecular-weight targets. It is intended for research gel preparation and denaturing or non-denaturing workflows, not diagnostic, clinical, or medical testing.

• Indomethacin for Inflammation Research Workflows

  2026-09-23

  Use Indomethacin to probe cyclooxygenase-dependent inflammatory signaling alongside pathways such as FXR–KLF11–JAK2/STAT3—not as a substitute for testing those pathways directly. This workflow combines dose-response design, vehicle controls, and orthogonal readouts to help distinguish COX inhibition from broader cellular effects.

• DCPS in Diabetic Foot Ulcer Epithelial Healing

  2026-09-23

  A 2025 World Journal of Diabetes study identifies the decapping scavenger enzyme DCPS as an m7G-related biomarker associated with epithelial dysfunction in diabetic foot ulcers. Integrated transcriptomic analysis and keratinocyte experiments connect reduced DCPS with cell-cycle disruption, impaired proliferation and migration, and increased apoptosis, while also defining important limits for causal and translational interpretation.

• FXR–KLF11 Signaling in Contrast-Induced Kidney Injury

  2026-09-22

  The reference study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by restraining JAK2/STAT3-driven inflammation and apoptosis. Its combination of mouse, renal epithelial cell, transcriptomic, reporter, chromatin, and genetic experiments provides a mechanistic framework for evaluating FXR-directed prophylaxis.

• Acetylspiramycin: A Smarter MIC Study Framework

  2026-09-22

  Acetylspiramycin (Spiramycin B) offers a practical way to refine macrolide susceptibility studies under rising resistance. This article translates recent Mycoplasma pneumoniae findings into assay design, interpretation, and host-pathogen research decisions.

• FKBP9, ER Stress, and Glioblastoma Resistance

  2026-09-21

  Xu et al. identify FKBP9 as an oncogenic factor that supports glioblastoma growth while buffering cells against endoplasmic reticulum stress. Their integrated clinical, cellular, mechanistic, and in vivo experiments connect FKBP9 with ASK1–p38MAPK signaling, the IRE1α–XBP1 unfolded protein response, and resistance to ER stress inducers.

• Carrier-Free Triterpene Prodrug for OSCC

  2026-09-21

  This ACS Applied Materials & Interfaces study developed a carrier-free prodrug assembled from glycyrrhetinic acid and ginsenoside Rh2 for targeted oral squamous cell carcinoma therapy. Its design combines glucose-associated uptake, ROS-responsive thioketal cleavage, and glycyrrhetinic-acid-driven oxidative amplification to promote synergistic apoptosis while avoiding a separate nanocarrier.

• SB 225002: CXCR2 Antagonist for Neutrophil Research

  2026-09-20

  SB 225002, also called SB225002, is a selective non-peptide CXCR2 antagonist for studying IL-8- and GROα-driven neutrophil trafficking. Its reported 22 nM IL-8 binding benchmark and greater than 150-fold CXCR2 preference over CXCR1 support receptor-dissection studies, but they do not establish activity against CXCR1-dependent tumor-cell signaling.

• ABT-199 (Venetoclax) Apoptosis Workflow

  2026-09-19

  Build a dependency-guided apoptosis workflow with ABT-199 (Venetoclax), from DMSO stock preparation through orthogonal cell-death validation. Its strong BCL-2 selectivity makes it especially useful for B-cell models, while the reference study provides a practical warning: senescent solid-tumor cells may depend on different anti-apoptotic proteins.

• Dendritic Cell mRNA Electroporation: Evidence and Design

  2026-09-18

  This study showed that electroporating mature dendritic cells can improve the combined performance of mRNA delivery, cell survival, antigen expression, and T-cell stimulation compared with electroporating immature cells. Its pulse-comparison strategy provides a useful framework for interpreting reporter fluorescence alongside phenotype and immune function rather than treating transfection efficiency as the sole endpoint.

8617 records 1/575 page Next 12345 下5页 Last page